(5-Phenyl-1,3,4-oxadiazol-2-yl)methylamine, 95.0%, 25g

1-(4-Bromophenyl)-3,5-dimethyl-1H-pyrazole-4-carboxaldehyde, 95.0%, 500mg

4-Bromo-2,3-difluorobenzaldehyde, 98.0%, 25g

Acido 4-nitroantranilico, minimo 98%, per sintesi, 5 g, confezione in vetro

n-(2-Morpholinoethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, 97%, 1g

Setaccio di prova Ø 200 mm, 9,5 mm, 1 Pezzo(i)

(S)-METHYL 2-AMINO-2-CYCLOPENTYLACETATE, 95.0%, 100mg

1-Fluoro-2,4,6-trimethylpyridinium tetrafluoroborate, 98.0%, 250mg

5-Chloro-1-methyl-4-nitroimidazole, 97.0%, 500g

4-bromo-5-ethyl-1-methyl-1H-pyrazole, 95.0%, 100mg

tert-Butyl (3-aminocyclobutyl)carbamate hydrochloride, 97%, 100mg

4-Bromo-1,5-dimethyl-naphthalene, 98%, 250mg

1-Methyl N-(tert-Butoxycarbonyl)-L-aspartate>97.0%(HPLC)(T)5g